After Losing His Son to Neuroblastoma, This Father is Singing to Raise Money for Cancer Support
Didgeman / Pixabay

After Losing His Son to Neuroblastoma, This Father is Singing to Raise Money for Cancer Support

According to a story from falmouthpacket.co.uk, couple Geoff and Judie Davis were devastated when their two year old boy Mikey died after being diagnosed with neuroblastoma. That was more than…

Continue Reading After Losing His Son to Neuroblastoma, This Father is Singing to Raise Money for Cancer Support

One Family’s Struggle with Danon Disease, a Rare Disorder Affecting a Mother and Both of Her Two Young Sons

In a story published in The Hernando Sun, Dawn Dybiec, age 31, describes her disbelief when she and her husband were told that her two sons, Gabriel and Steven, were…

Continue Reading One Family’s Struggle with Danon Disease, a Rare Disorder Affecting a Mother and Both of Her Two Young Sons

New Phase 1 Clinical Trial for Potential Oral Medication for Non-Tuberculous Mycobacterial (NTM) Infections

Non-tuberculous mycobacterial (NTM) infections are caused by bacteria found in the environment. In healthy individuals, these bacteria normally cause no harm. However, for those who have a compromised immune system or who…

Continue Reading New Phase 1 Clinical Trial for Potential Oral Medication for Non-Tuberculous Mycobacterial (NTM) Infections

Don’t Miss The Final Screening of “Take A Look At This Heart,” About Love and Intimacy in the Disabled Community

A rarely addressed subject that comes up in discussions about people with disabilities is the subject of romantic relationships, intimacy, and parenting. More than likely, a lot of day to…

Continue Reading Don’t Miss The Final Screening of “Take A Look At This Heart,” About Love and Intimacy in the Disabled Community
Xenon Issues Updates on Two of Its Investigational Drug Candidates
Skitterphoto / Pixabay

Xenon Issues Updates on Two of Its Investigational Drug Candidates

According to a story from globenewswire.com, the biopharmaceutical company Xenon Pharmaceuticals, Inc., recently announced the latest updates on the progress of two of its experimental products. The first is called…

Continue Reading Xenon Issues Updates on Two of Its Investigational Drug Candidates
This Research Partnership Will Investigate the Relationship Between Obesity and Pancreatic Cancer
Films42 / Pixabay

This Research Partnership Will Investigate the Relationship Between Obesity and Pancreatic Cancer

According to a story from prweb.com, researchers from the Johns Hopkins Kimmel Cancer Center and the Allegheny Health Network (AHC) Cancer Institute have entered a partnership that plans to investigate…

Continue Reading This Research Partnership Will Investigate the Relationship Between Obesity and Pancreatic Cancer
After The Death of a Loved One, This Couple is Determined to Find a Treatment for Fatal Familial Insomnia
AndCan / Pixabay

After The Death of a Loved One, This Couple is Determined to Find a Treatment for Fatal Familial Insomnia

According to a story from wired.com, everything changed for Sonia Vallabh and her husband Eric Minikel after Sonia's mother died from a mysterious illness. Sonia's mother Kamni was in her…

Continue Reading After The Death of a Loved One, This Couple is Determined to Find a Treatment for Fatal Familial Insomnia
Industry First: For-Profit Donates Rights of Potential New Pediatric Leukemia Drug to Non-Profit
source: pixabay.com

Industry First: For-Profit Donates Rights of Potential New Pediatric Leukemia Drug to Non-Profit

Notable Labs Notable Labs was created after founder, Matt De Silva, felt he was left in a helpless point, following a year of research on treatment options for his father's Glioblastoma…

Continue Reading Industry First: For-Profit Donates Rights of Potential New Pediatric Leukemia Drug to Non-Profit
Results of Levodopa Study Highlight Why Better Parkinson’s Disease Therapies are Needed
sabinevanerp / Pixabay

Results of Levodopa Study Highlight Why Better Parkinson’s Disease Therapies are Needed

According to a story from Parkinson's News Today, a recent study published in the New England Journal of Medicine highlights the key weakness of Levodopa, one of the most common treatments…

Continue Reading Results of Levodopa Study Highlight Why Better Parkinson’s Disease Therapies are Needed
Recently Approved Drug Ultomiris Performs Well in Atypical Hemolytic Uremic Syndrome Trial
qimono / Pixabay

Recently Approved Drug Ultomiris Performs Well in Atypical Hemolytic Uremic Syndrome Trial

According to a story from statnews.com, the biotechnology company Alexion Pharmaceuticals recently announced that its product Ultomiris, which was recently approved as a treatment for paroxysmal nocturnal hemoglobinuria, was also…

Continue Reading Recently Approved Drug Ultomiris Performs Well in Atypical Hemolytic Uremic Syndrome Trial